Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)

Clinical trial NCT00560833 · COMPLETED

Trial details

NCT number: NCT00560833
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Menopause Vasomotor Symptoms

Start date: 2004-10-15
Primary completion: 2006-01-15
Enrollment: 943

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.